Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Menopause Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The market size for menopause-related products and services has experienced robust growth recently. This market is projected to expand from $18.78 billion in 2025 to $19.95 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been driven by factors such as an aging female demographic, enhanced life expectancy for women, the extensive adoption of hormone replacement therapy, rising recognition of menopausal symptoms, and the broadening of women’s healthcare provisions.

The menopause market is projected to demonstrate significant growth in the upcoming years. By 2030, it is forecast to expand to $26.21 billion, achieving a compound annual growth rate (CAGR) of 7.1%. Contributing to this growth during the forecast period are factors such as the increasing demand for safer long-term therapies, the expansion of digital health platforms dedicated to menopause, an elevated focus on preventive women’s health, enhanced access to online pharmacies, and a wider acceptance of alternative and lifestyle-based treatments. Significant trends expected in the forecast period include the increasing adoption of non-hormonal menopause treatments, greater awareness and proactive management of menopause, a growing preference for dietary supplements and natural remedies, the proliferation of personalized menopause care programs, and a heightened demand for symptom-specific treatment solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp

Menopause Market Expansion Supported By Key Demand Factors

The menopause market is anticipated to expand due to the growing trend of evolving lifestyles. An evolving lifestyle encompasses alterations in individuals’ living habits and decisions affecting their health and overall welfare. During this natural biological stage, adapting one’s lifestyle can assist in managing menopausal symptoms and improving overall well-being. Menopause can prompt various lifestyle modifications, such as adopting a nutritious diet, regular physical activity, adequate sleep, avoiding smoking and excessive alcohol consumption, and participating in calming pastimes. For example, a press release from the US-based Global Wellness Institution in November 2023 indicated that in 2022, the wellness economy accounted for 5.6% of global economic output and is forecast to reach $8.5 trillion by 2027, demonstrating an average annual growth rate of 8.6%. Consequently, the escalating adoption of changing lifestyles is fueling the expansion of the menopause market.

Menopause Market Segment Performance And Strategic Opportunities

The menopause market covered in this report is segmented –

1) By Treatment: Dietary Supplements, Over-The-Counter (OTC) Pharma Products

2) By Route Of Administration: Topical, Oral, Injectables

3) By Distribution Channel: Hospital, Retail, Online Pharmacies

4) By End User: Hospital, Diagnostic Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Dietary Supplements: Herbal Supplements, Vitamins And Minerals, Phytoestrogens, Omega-3 Fatty Acids, Probiotics

2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT), Non-Hormonal OTC Products, Antidepressants For Mood Swings, Sleep Aids, Pain Relievers

Menopause Market Growth Trends Influencing Competitive Dynamics

Leading companies in the menopause market are prioritizing the development of innovative therapies, such as dual neurokinin 1/neurokinin 3 (NK1/NK3) receptor antagonists, to provide non-hormonal alternatives for vasomotor symptoms (hot flashes and night sweats) and enhance the quality of life for menopausal women. Dual neurokinin 1/neurokinin 3 receptor antagonists are oral pharmaceuticals designed to concurrently block both NK1 and NK3 receptors in the hypothalamus, consequently modulating the neuropeptide pathways responsible for thermoregulation and sweat responses, which reduces the frequency and severity of hot flashes and associated sleep disturbances. For example, in October 2025, Bayer AG, a Germany-based pharmaceutical company, secured approval from the U.S. Food and Drug Administration (FDA) for Lynkuet (elinzanetant) 60 mg capsules. This product is recognized as the world’s first dual-NK1/NK3 receptor antagonist sanctioned for addressing moderate to severe hot flashes resulting from menopause. Lynkuet provides once-daily bedtime dosing, demonstrated significant reductions in both the frequency and severity of hot flashes across three Phase III trials (OASIS 1/2/3), and employs a non-hormonal mechanism of action, thereby expanding treatment possibilities for women for whom hormone therapy is contraindicated.

Menopause Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the menopause market are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., Serenity Pharmaceuticals LLC

Access The Complete Menopause Market Report:

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Menopause Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the menopause market in 2025. The regions covered in the menopause market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.